October 20, 2021

Volume XI, Number 293

Advertisement
Advertisement

October 19, 2021

Subscribe to Latest Legal News and Analysis

October 18, 2021

Subscribe to Latest Legal News and Analysis
Advertisement

Judge Michel Takes “Patent Reform” Bills To Task

In an interview with Intellectual Property Watch, former Chief Judge Paul R. Michel set forth, in one place, all of the most problematic (Ed.: read, “worst”) features of the Leahy Smith America Invents Act, versions of which have been passed by the House and the Senate.

The interview focuses both on the special interest features of the Senate bill such as those invalidating tax strategy patents and expanding prior user rights. He also notes the weaknesses in the House bill potentially limiting PTO full access to all the user fees it collects. He notes the flaws in the one-year grace period for inventor-generated disclosures and opposes the additional burdens on patentees imposed by post-grant review.

Wearing my patent prosecutor hat, I see little to like about this bill. Its roots are in oft-parroted but flawed analyses that suggest the U.S. economy is somehow being damaged by “flawed patents.” However, almost every feature of the bill simply makes patent protection more difficult to obtain, or weakens patent protection, for small start-ups and universities, as well as for mega-industries. Coupled with anti-patent decisions such as KSR, Bilski and Ariad, (the “jury” is still out on Prometheus, Myriad and Classen) pioneering inventions, particularly in early-stage technologies, are in for a very bumpy ride.

© 2021 Schwegman, Lundberg & Woessner, P.A. All Rights Reserved.National Law Review, Volume I, Number 199
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Warren Woessner, Registered Patent Attorney, Schwegman Lundberg Law firm
Shareholder

Warren Woessner is a registered patent attorney and a founding shareholder of Schwegman, Lundberg & Woessner. His practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters.

Warren received his B.A. in chemistry (1966) from Cornell University, his Ph.D. (organic chemistry, 1971) and his law degree (J.D., cum laude, 1981) from the University of Wisconsin...

612-373-6900
Advertisement
Advertisement
Advertisement